TRANEXAMIC ACID – not licensed specifically for uterine fibroids Licensed for treatment of cyclic heavy menstrual bleeding Post-hoc analyses from two pivotal Phase 3 studies… Read More
Reintervention rates after myomectomy*: 76.2% for laparoscopic myomectomy 63.4% for abdominal myomectomy Since the FDA warning in 2014 to utilise safer morcellation methods3, there… Read More
A nationwide cohort study* in >800,000 Swedish women, evaluated the risk of cardiovascular disease (CVD) following a hysterectomy for benign indications1 In women under 50… Read More
Although surgery is essential in some cases, it is not suitable for all women1 There are short- and long-term risks associated with hysterectomy and myomectomy1… Read More
“…my period lasted for 30 days and it was heavy and it was horrible. I was wearing pads like the size that you get in… Read More
Uterine fibroids affect millions of women worldwide2 70-80% of women are affected by menopausal age3 Uterine fibroids are considered a public health concern in some… Read More
Perhaps this typifies the stigma and taboo many women still feel about discussing some aspects of female health A large study across all US states… Read More